Reticulation Sign on Thin-Section CT: Utility for Predicting Invasiveness of Pure Ground-Glass Nodules

Early Lung Adenocarcinoma Manifesting as Irregular Subsolid Nodules: Clinical and CT Characteristics

RATIONALE AND OBJECTIVES

To explore the clinical and computed tomography (CT) characteristics of early-stage lung adenocarcinoma (LADC) that presents with an irregular shape.

MATERIALS AND METHODS

The CT data of 575 patients with stage IA LADC and 295 with persistent inflammatory lesion (PIL) manifesting as subsolid nodules (SSNs) were analyzed retrospectively. Among these patients, we selected 233 patients with LADC and 140 patients with PIL, who showed irregular SSNs, hereinafter referred to as irregular LADC (I-LADC) and irregular PIL (I-PIL), respectively. The incidence rates, clinical characteristics, and CT features of I-LADC and I-PIL were compared. Additionally, binary logistic regression analysis was performed to determine the independent factors for diagnosing I-LADC.

RESULTS

The incidence rates of I-LADC and I-PIL were 40.5% (233/575) and 47.5% (140/295), respectively, with no statistically significant difference observed between the two groups (P > 0.05). Univariate analysis revealed significant differences in three clinical characteristics and 13 radiological features between I-LADC and I-PIL (all P < 0.05). Binary logistic regression indicated that the alignment of the long axis of SSN with the bronchial vascular bundle, a well-defined boundary of ground-glass opacity, lobulation, arc concave sign, and absence of knife-like change were the independent predictors of I-LADC, yielding an area under the curve and accuracy of 0.979% and 93.5%, respectively.

CONCLUSION

Early LADC presenting as SSNs is associated with a high incidence of irregular shape. I-LADC and I-PIL exhibited different clinical and imaging characteristics. A good understanding of these differences may be helpful for the accurate diagnosis of I-LADC.

Photon-counting detector CT provides superior subsolid nodule characterization compared to same-day energy-integrating detector CT

PURPOSE

To investigate the image quality and the performance of photon-counting detector (PCD) CT compared to conventional energy-integrating detector (EID) CT in identifying subsolid nodule (SSN) characteristics.

MATERIALS AND METHODS

Participants with SSNs who underwent same-day EID CT and PCD CT between October 2023 and April 2024 were prospectively included. The 1.0 mm EID CT images and, subsequently, 1.0 mm, 0.4 mm, and 0.2 mm PCD CT images were reviewed to assess image noise and subjective image quality on a 5-point Likert scale. SSN characteristics, including lobulation, spiculation, pleural retraction, air cavities, intra-nodular vessel signs, internal vascular changes, and heterogeneous solid components, were evaluated. Additionally, a step-by-step observation and comparison method was used to determine the presence of any additional characteristics.

RESULTS

Forty-eight participants (mean age: 56 ± 11 years; 16 males) with 89 SSNs were included. PCD CT significantly reduced radiation dose when using matched scans (1.79 ± 0.39 vs 2.17 ± 0.57 mSv, p < 0.001). Compared to 1.0 mm EID CT, 1.0 mm PCD CT images exhibited significantly lower objective image noise and higher subjective image quality (all p < 0.001). Compared to EID CT, PCD CT demonstrated enhanced visualization of subtle characteristics, except for lobulation, with a 0.4 mm section thickness offering a favorable balance between ultra-high resolution and perceived image quality for radiologists.

CONCLUSION

PCD CT facilitated radiation dose reduction and outperformed conventional EID CT in terms of image quality and visualization of SSN characteristics.

KEY POINTS

Question PCD CT, featuring ultra-high-resolution mode acquisition and a thinner reconstruction, has not been fully explored for characterizing SSNs. Findings Compared to EID CT, PCD CT was associated with lower objective image noise, higher subjective image quality, and superior SSN characterization. Clinical relevance PCD CT effectively reduced the radiation dose delivered to the patients and enabled more precise SSN characterization.

Clinical Outcomes of Resected Pure Ground-Glass, Heterogeneous Ground-Glass, and Part-Solid Pulmonary Nodules

BACKGROUND. Increased (but not definitively solid) attenuation within pure ground-glass nodules (pGGNs) may indicate invasive adenocarcinoma and the need for resection rather than surveillance. OBJECTIVE. The purpose of this study was to compare the clinical outcomes among resected pGGNs, heterogeneous ground-glass nodules (GGNs), and part-solid nodules (PSNs). METHODS. This retrospective study included 469 patients (335 female patients and 134 male patients; median age, 68 years [IQR, 62.5-73.5 years]) who, between January 2012 and December 2020, underwent resection of lung adenocarcinoma that appeared as a subsolid nodule on CT. Two radiologists, using lung windows, independently classified each nodule as a pGGN, a heterogeneous GGN, or a PSN, resolving discrepancies through discussion. A heterogeneous GGN was defined as a GGN with internal increased attenuation not quite as dense as that of pulmonary vessels, and a PSN was defined as having an internal solid component with the same attenuation as that of the pulmonary vessels. Outcomes included pathologic diagnosis of invasive adenocarcinoma, 5-year recurrence rates (locoregional or distant), and recurrence-free survival (RFS) and overall survival (OS) over 7 years, as analyzed by Kaplan-Meier and Cox proportional hazards regression analyses, with censoring of patients with incomplete follow-up. RESULTS. Interobserver agreement for nodule type, expressed as a kappa coefficient, was 0.69. Using consensus assessments, 59 nodules were pGGNs, 109 were heterogeneous GGNs, and 301 were PSNs. The frequency of invasive adenocarcinoma was 39.0% in pGGNs, 67.9% in heterogeneous GGNs, and 75.7% in PSNs (for pGGNs vs heterogeneous GGNs, p < .001; for pGGNs vs PSNs, p < .001; and for heterogeneous GGNs vs PSNs, p = .28). The 5-year recurrence rate was 0.0% in patients with pGGNs, 6.3% in those with heterogeneous GGNs, and 10.8% in those with PSNs (for pGGNs vs heterogeneous GGNs, p = .06; for pGGNs vs PSNs, p = .02; and for heterogeneous GGNs vs PSNs, p = .18). At 7 years, RFS was 97.7% in patients with pGGNs, 82.0% in those with heterogeneous GGNs, and 79.4% in those with PSNs (for pGGNs vs heterogeneous GGNs, p = .02; for pGGNs vs PSNs, p = .006; and for heterogeneous GGNs vs PSNs, p = .40); OS was 98.0% in patients with pGGNs, 84.6% in those with heterogeneous GGNs, and 82.9% in those with PSNs (for pGGNs vs heterogeneous GGNs, p = .04; for pGGNs vs PSNs, p = .01; and for heterogeneous GGNs vs PSNs, p = .50). CONCLUSION. Resected pGGNs had excellent clinical outcomes. Heterogeneous GGNs had relatively worse outcomes, more closely resembling outcomes for PSNs. CLINICAL IMPACT. The findings support surveillance for truly homogeneous pGGNs versus resection for GGNs showing internal increased attenuation even if not having a true solid component.

A nomogram combining thoracic CT and tumor markers to predict the malignant grade of pulmonary nodules ≤3 cm in diameter

Background

With the popularity of computed tomography (CT) of the thorax, the rate of diagnosis for patients with early-stage lung cancer has increased. However, distinguishing high-risk pulmonary nodules (HRPNs) from low-risk pulmonary nodules (LRPNs) before surgery remains challenging.

Methods

A retrospective analysis was performed on 1064 patients with pulmonary nodules (PNs) admitted to the Qilu Hospital of Shandong University from April to December 2021. Randomization of all eligible patients to either the training or validation cohort was performed in a 3:1 ratio. Eighty-three PNs patients who visited Qianfoshan Hospital in the Shandong Province from January through April of 2022 were included as an external validation. Univariable and multivariable logistic regression (forward stepwise regression) were used to identify independent risk factors, and a predictive model and dynamic web nomogram were constructed by integrating these risk factors.

Results

A total of 895 patients were included, with an incidence of HRPNs of 47.3% (423/895). Logistic regression analysis identified four independent risk factors: the size, consolidation tumor ratio, CT value of PNs, and carcinoembryonic antigen levels in blood. The area under the ROC curves was 0.895, 0.936, and 0.812 for the training, internal validation, and external validation cohorts, respectively. The Hosmer-Lemeshow test demonstrated excellent calibration capability, and the fit of the calibration curve was good. DCA has shown the nomogram to be clinically useful.

Conclusion

The nomogram performed well in predicting the likelihood of HRPNs. In addition, it identified HRPNs in patients with PNs, achieved accurate treatment with HRPNs, and is expected to promote their rapid recovery.